Neostigmine
17 brands · 13 companies · product forms
Opportunity snapshot
Who competes here
Top companies by brand count — fragmented market (no dominant player) · leader share 12%
Price room
max/min price ratio 25.09x across 6 trusted points (Rs 82.07-2059.06). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Brands & products on the market
Sample of 9 live products for Neostigmine — each links to its own medicine page.
Regulatory alerts
Why this score
Launch attractiveness
40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(67) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.
Market saturation
13 canonical companies and 17 brands compete (saturation pegged at 30 companies / 150 brands).
Price room
max/min price ratio 25.09x across 6 trusted points (Rs 82.07-2059.06). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.
Regulatory risk
1 DRAP alert(s), latest 2024-10-28 incl. recall/safety.
Confidence
Full coverage.
Packaged brief for this strong opportunity?
Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.
See packaged reports All 3868 molecules